159 related articles for article (PubMed ID: 21403827)
41. Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
Kitayama W; Denda A; Okajima E; Tsujiuchi T; Konishi Y
Carcinogenesis; 1999 Dec; 20(12):2305-10. PubMed ID: 10590224
[TBL] [Abstract][Full Text] [Related]
42. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
43. Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin.
Tanaka T; Morishita Y; Suzui M; Kojima T; Okumura A; Mori H
Carcinogenesis; 1994 Jan; 15(1):15-9. PubMed ID: 8293542
[TBL] [Abstract][Full Text] [Related]
44. Possible mechanistic roles of anatomical and functional vascular changes in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Tatematsu M; Lurie AG; Rippey RM; Conran PB; Arai M; Fukushima S; Ito N
Cancer Res; 1984 Jan; 44(1):278-84. PubMed ID: 6690039
[TBL] [Abstract][Full Text] [Related]
45. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Becci PJ; Thompson HJ; Grubbs CJ; Squire RA; Brown CC; Sporn MB; Moon RC
Cancer Res; 1978 Dec; 38(12):4463-6. PubMed ID: 719631
[TBL] [Abstract][Full Text] [Related]
46. Absence of promoting potential of bracken fern (Pteridium aquilinum) in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine and uracil.
de Oliveira ML; Souza Rocha N; Fukushima S; de Camargo JL
Teratog Carcinog Mutagen; 1995; 15(4):191-9. PubMed ID: 8838633
[TBL] [Abstract][Full Text] [Related]
47. Modulation of carcinogenesis in the urinary bladder by retinoids.
Hicks RM; Turton JA; Chowaniec J; Tomlinson CN; Gwynne J; Nandra K; Chrysostomou E; Pedrick M
Ciba Found Symp; 1985; 113():168-90. PubMed ID: 3849405
[TBL] [Abstract][Full Text] [Related]
48. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Hiasa Y; Kitahori Y; Konishi N; Shimoyama T; Miyashiro A
J Natl Cancer Inst; 1985 Jan; 74(1):235-9. PubMed ID: 3855482
[TBL] [Abstract][Full Text] [Related]
49. Antitumour effects of the angiogenesis inhibitor AGM-1470 on rat urinary bladder tumours induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
Osawa S; Terashima Y; Kimura G; Akimoto M
BJU Int; 1999 Jan; 83(1):123-8. PubMed ID: 10233464
[TBL] [Abstract][Full Text] [Related]
50. Chemopreventive Potential of Myrtenal against Nitrosamine-Initiated, Radiation-Promoted Rat Bladder Carcinogenesis.
Farrag MA; Ezz MK; Ibrahim NK; Ahmed EK
Nutr Cancer; 2022; 74(1):288-298. PubMed ID: 33511885
[TBL] [Abstract][Full Text] [Related]
51. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer.
Gee J; Lee IL; Jendiroba D; Fischer SM; Grossman HB; Sabichi AL
Oncol Rep; 2006 Feb; 15(2):471-7. PubMed ID: 16391871
[TBL] [Abstract][Full Text] [Related]
52. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
Kawamori T; Rao CV; Seibert K; Reddy BS
Cancer Res; 1998 Feb; 58(3):409-12. PubMed ID: 9458081
[TBL] [Abstract][Full Text] [Related]
53. Chemoprevention of urinary bladder carcinogenesis by the natural phenolic compound protocatechuic acid in rats.
Hirose Y; Tanaka T; Kawamori T; Ohnishi M; Makita H; Mori H; Satoh K; Hara A
Carcinogenesis; 1995 Oct; 16(10):2337-42. PubMed ID: 7586132
[TBL] [Abstract][Full Text] [Related]
54. Chemoprevention by indomethacin of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumors.
Grubbs CJ; Juliana MM; Eto I; Casebolt T; Whitaker LM; Canfield GJ; Manczak M; Steele VE; Kelloff GJ
Anticancer Res; 1993; 13(1):33-6. PubMed ID: 8476227
[TBL] [Abstract][Full Text] [Related]
55. [Effect of carboquone (esquinone) on the development of urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine].
Okajima E; Hiramatsu T; Okamoto M; Kihoin K; Ijuin M; Hirao Y; Ohara S; Babaya K; Kubota K; Samma S; Okamura K; Kaneko Y; Horii Y; Moriya A
Gan To Kagaku Ryoho; 1982 May; 9(5):836-42. PubMed ID: 7184430
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of tumor development in the regenerating rat urinary bladder stimulated to proliferate by cyclophosphamide.
Kunze E; Töpfer S; Zöller N
Eur J Cancer Clin Oncol; 1984 May; 20(5):711-7. PubMed ID: 6539704
[TBL] [Abstract][Full Text] [Related]
57. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
Chen T; Na Y; Wanibuchi H; Yamamoto S; Lee CC; Fukushima S
Jpn J Cancer Res; 1999 Aug; 90(8):818-23. PubMed ID: 10543252
[TBL] [Abstract][Full Text] [Related]
58. Acetylsalicylic acid inhibition of n-butyl-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats.
Klän R; Knispel HH; Meier T
J Cancer Res Clin Oncol; 1993; 119(8):482-5. PubMed ID: 8509438
[TBL] [Abstract][Full Text] [Related]
59. Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.
Lubet RA; Fischer SM; Steele VE; Juliana MM; Desmond R; Grubbs CJ
Int J Cancer; 2008 Nov; 123(10):2254-9. PubMed ID: 18712722
[TBL] [Abstract][Full Text] [Related]
60. Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder.
Rao KV; Detrisac CJ; Steele VE; Hawk ET; Kelloff GJ; McCormick DL
Carcinogenesis; 1996 Jul; 17(7):1435-8. PubMed ID: 8706245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
